Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: IVC

This article was originally published in The Tan Sheet

Executive Summary

IVC: Formerly known as International Vitamin Corp., completes acquisition of Hall Laboratories. Under the merger agreement, valued at about $12 mil., IVC issued Hall 3.8 mil. shares to Hall Labs' shareholders. The companies signed a letter of intent in June 1995 ("The Tan Sheet" June 5, 1995, p. 3). In addition, IVC said it has entered into a $26.5 mil. financing facility with Chase Manhattan Bank. The funds will be used to consolidate the two companies' obligations, including start-up costs for IVC's new Intergel brand softgel manufacturing facility and promotional costs associated with the launch of the new Revlon vitamin line, estimated to be "in excess of $3 mil." The companies will retain their current management, but will be governed by a new board comprised both of former heads of IVC and Hall Labs and new members to the firm. IVC is predicting FY 1996 sales of about $100 mil...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085355

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel